BIOTRICITY INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)
BIOTRICITY INC. (BTCY) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) of $105.62 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease · last filed 2026-08-19
- BIOTRICITY INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2026-06-30 was $105.62K, a 3665.28% increase year-over-year.
- BIOTRICITY INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2026-03-31 was -$14.07K, a 121.34% decline year-over-year.
- BIOTRICITY INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2025-12-31 was $133.73K.
- BIOTRICITY INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2025-09-30 was $3.35K, a 98.56% decline year-over-year.
- BIOTRICITY INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for fiscal 2025 was $553.21K.
- BIOTRICITY INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for fiscal 2024 was -$92.96K, a 120.22% decline from fiscal 2023.
- BIOTRICITY INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for fiscal 2023 was $459.70K, a 15.47% increase from fiscal 2022.
- BIOTRICITY INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for fiscal 2022 was $398.11K.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 3 month as first filed | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 12 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $105.62K 10-Q · filed 2026-08-19 | $91.55K derived: sum of 2 quarters · filed 2026-08-19 | $225.28K derived: sum of 3 quarters · filed 2026-08-19 | $228.63K derived: sum of 4 quarters · filed 2026-08-19 | ||
| 2026-03-31 | -$14.07K derived: 10-Q 12 month − 10-Q 9 month · filed 2026-08-19 | $119.66K derived: sum of 2 quarters · filed 2026-08-19 | $123.01K derived: sum of 3 quarters · filed 2026-08-19 | $125.81K 10-Q · filed 2026-08-19 | ||
| 2025-12-31 | $133.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-11 | $137.08K derived: sum of 2 quarters · filed 2026-02-11 | $139.88K 10-Q · filed 2026-02-11 | $205.82K derived: sum of 4 quarters · filed 2026-07-14 | ||
| 2025-09-30 | $3.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-14 | $6.16K 10-Q · filed 2025-11-14 | $72.09K derived: sum of 3 quarters · filed 2026-07-14 | $26.24K derived: sum of 4 quarters · filed 2026-07-14 | ||
| 2025-06-30 | $2.81K 10-Q · filed 2025-08-14 | $68.74K derived: sum of 2 quarters · filed 2026-07-14 | $22.89K derived: sum of 3 quarters · filed 2026-07-14 | $255.57K derived: sum of 4 quarters · filed 2026-07-14 | ||
| 2025-03-31 | $65.94K derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-07-14 | $20.08K derived: sum of 2 quarters · filed 2026-07-14 | $252.77K derived: sum of 3 quarters · filed 2026-07-14 | $553.21K 10-K · filed 2026-07-14 | ||
| 2024-12-31 | -$45.85K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2025-02-20 | $186.83K derived: sum of 2 quarters · filed 2025-11-14 | $487.27K 10-Q/A · filed 2025-02-20 | $537.14K derived: sum of 4 quarters · filed 2025-11-14 | ||
| 2024-09-30 | $232.69K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-14 | $533.13K 10-Q · filed 2025-11-14 | $583.00K derived: sum of 3 quarters · filed 2025-11-14 | $490.20K derived: sum of 4 quarters · filed 2025-11-14 | ||
| 2024-06-30 | $300.44K 10-Q · filed 2025-08-14 | $350.31K derived: sum of 2 quarters · filed 2025-08-14 | $257.51K derived: sum of 3 quarters · filed 2025-08-14 | $287.30K derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | $49.87K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2025-07-18 | -$42.93K derived: sum of 2 quarters · filed 2025-07-18 | -$13.13K derived: sum of 3 quarters · filed 2025-07-18 | -$92.96K 10-K/A · filed 2025-07-18 | ||
| 2023-12-31 | -$92.80K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2025-02-20 | -$63.00K derived: sum of 2 quarters · filed 2025-02-20 | -$142.83K 10-Q/A · filed 2025-02-20 | -$125.44K derived: sum of 4 quarters · filed 2025-02-20 | ||
| 2023-09-30 | $29.79K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-14 | -$50.03K 10-Q · filed 2024-11-14 | -$32.64K derived: sum of 3 quarters · filed 2024-11-14 | -$110.67K derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | -$79.83K 10-Q · filed 2024-08-19 | -$62.44K derived: sum of 2 quarters · filed 2024-08-19 | -$140.46K derived: sum of 3 quarters · filed 2024-08-19 | -$309.23K derived: sum of 4 quarters · filed 2024-08-19 | ||
| 2023-03-31 | $17.39K derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-27 | -$60.64K derived: sum of 2 quarters · filed 2024-06-27 | -$229.40K derived: sum of 3 quarters · filed 2024-06-27 | $459.70K 10-K · filed 2024-06-27 | ||
| 2022-12-31 | -$78.03K 10-Q · filed 2023-02-14 | -$246.79K derived: sum of 2 quarters · filed 2023-02-14 | $442.31K 10-Q · filed 2024-02-20 | -$109.90K derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-09-30 | -$168.76K 10-Q · filed 2023-02-14 | $364.28K 10-Q · filed 2023-11-14 | -$31.88K derived: sum of 3 quarters · filed 2023-08-14 | -$676.65K derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-06-30 | $195.52K 10-Q · filed 2023-08-14 | -$195.52K 10-Q · filed 2022-08-15 | $136.89K derived: sum of 2 quarters · filed 2023-08-14 | -$507.89K derived: sum of 3 quarters · filed 2023-08-14 | -$406.71K derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | -$58.63K 10-K · filed 2022-07-14 | -$703.41K derived: sum of 2 quarters · filed 2023-02-14 | -$602.24K derived: sum of 3 quarters · filed 2023-02-14 | $398.11K 10-K · filed 2023-06-29 | ||
| 2021-12-31 | -$644.77K 10-Q · filed 2023-02-14 | -$543.60K derived: sum of 2 quarters · filed 2023-02-14 | -$340.08K derived: sum of 3 quarters · filed 2023-02-14 | |||
| 2021-09-30 | $101.17K 10-Q · filed 2023-02-14 | $101.78K 10-Q · filed 2021-11-04 | $304.70K derived: sum of 2 quarters · filed 2023-02-14 | |||
| 2021-06-30 | $203.53K 10-Q · filed 2023-02-14 | |||||
| 2021-03-31 | $776.44K 10-Q · filed 2022-02-14 | -$776.44K 10-K · filed 2021-06-22 | ||||
| 2020-09-30 | -$178.99K 10-Q · filed 2020-11-13 | -$220.74K derived: sum of 2 quarters · filed 2021-08-17 | ||||
| 2020-06-30 | -$41.75K 10-Q/A · filed 2021-08-17 | -$204.14K 10-Q · filed 2020-08-14 | ||||
| 2020-03-31 | $60.78K 10-Q · filed 2020-11-13 | |||||
| 2019-12-31 | -$1.05K 10-Q · filed 2020-02-14 | |||||
| 2017-06-30 | $42.13K 10-Q · filed 2020-02-14 |